Skip to main content

Table 2 HIV Positive Participants Clinical Characteristics

From: Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe

CharacteristicMedian (IQR)
aCD4 count (cells/mm3)520 (300–699)
Nadir CD4 count (cells/mm3)250 (135–430)
Time since HIV Diagnosis (Months)73 (30–113)
Time since ART Initiation (Months)69 (29–107)
bAdherence Self Report Score24.5 (21–25)
Current ART RegimenFrequency
First Line ART regimen
 Stavudine/Lamivudine/Nevirapine2%
 Tenofovir/Lamivudine/Nevirapine2%
 Zidovudine/Lamivudine/Nevirapine1%
 Tenofovir/Lamivudine/Efavirenz93%
Second Line ART regimen
 Abacavir/Lamivudine/Atazanavir2%
Medication Switched Since Initiation
 Yes30%
 No70%
  1. Note: aMost recent CD4 count as per clinic records. bScored out of 25